TY - JOUR
KW - SGLT2 inhibitors
KW - Uti
KW - Cohort study
KW - drug safety
KW - pharmaco-epidemiology
KW - Type 2 diabetes
AU - W. Alkabbani
AU - A. Zongo
AU - J. Minhas-Sandhu
AU - D. Eurich
AU - B. Shah
AU - M. Alsabbagh
AU - J. Gamble
AD - School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
Faculty of Pharmacy and CHU de Québec Research Center, Université Laval, Québec City, Québec, Canada.
School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada; School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Endocrinology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada. Electronic address: jm.gamble@uwaterloo.ca.
AN - 35513988
BT - Can J Diabetes
DO - 10.1016/j.jcjd.2021.12.005
DP - NLM
ET - 2022/05/07
LA - eng
N1 - 2352-3840
Alkabbani, Wajd
Zongo, Arsène
Minhas-Sandhu, Jasjeet K
Eurich, Dean T
Shah, Baiju R
Alsabbagh, Mhd Wasem
Gamble, John-Michael
Journal Article
Canada
Can J Diabetes. 2021 Dec 30:S1499-2671(21)00472-X. doi: 10.1016/j.jcjd.2021.12.005.
PY - 2021
SN - 1499-2671
T2 - Can J Diabetes
TI - Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score-matched Population-based Cohort Study
ER -